In addition, CA4 can inhibit CRC progression by inducing WTAP degradation through polyubiquitination, and CA4 also inhibits the Wnt/β-linked protein signaling pathway by activating the WTAP degradation product WT-1 [114]. Here, WTAP is linked to colorectal carcinoma.